Steinberg E A, Overturf G D, Baraff L J, Wilkins J
Antimicrob Agents Chemother. 1977 Jun;11(6):933-5. doi: 10.1128/AAC.11.6.933.
Twelve patients, aged 6 months to 62 years, with proven bacterial meningitis, were given a single intravenous dose of cefamandole (33 mg/kg) 75 to 140 min before a routine lumbar puncture. Infecting organisms included Haemophilus influenzae (eight cases), Streptococcus pneumoniae (two cases), and Neisseria meningitidis and beta-hemolytic streptococcus (one each). Cerebrospinal fluid (CSF) was analyzed by microbiological assay for cefamandole. The median concentration was 0.60 mug/ml, ranging from undetectable to 7.4 mug/ml. CSF cefamandole concentrations correlated with CSF protein: in six patients with CSF protein less than 100 mug/dl, the range of drug concentration was 0 to 0.62 mug/ml; and in six patients with CSF protein above 100 mg/dl, the range was 0.57 to 7.4 mug/ml. No significant correlation was noted between severity of illness, type of organism involved, or patient age and concentration of drug achieved.
12名年龄在6个月至62岁之间、确诊为细菌性脑膜炎的患者,在进行常规腰椎穿刺前75至140分钟接受了单次静脉注射头孢孟多(33毫克/千克)。感染病原体包括流感嗜血杆菌(8例)、肺炎链球菌(2例)、脑膜炎奈瑟菌和β溶血性链球菌(各1例)。通过微生物学检测分析脑脊液(CSF)中的头孢孟多。中位浓度为0.60微克/毫升,范围从检测不到到7.4微克/毫升。脑脊液头孢孟多浓度与脑脊液蛋白相关:6例脑脊液蛋白低于100微克/分升的患者,药物浓度范围为0至0.62微克/毫升;6例脑脊液蛋白高于100毫克/分升的患者,浓度范围为0.57至7.4微克/毫升。在疾病严重程度、所涉及的病原体类型或患者年龄与所达到的药物浓度之间未发现显著相关性。